Fulgent Genetics Stock Price Prediction
| FLGT Stock | USD 16.87 0.26 1.52% |
Momentum 51
Impartial
Oversold | Overbought |
Quarterly Earnings Growth (0.99) | EPS Estimate Next Quarter (0.13) | EPS Estimate Current Year (0.66) | EPS Estimate Next Year (0.63) | Wall Street Target Price 20 |
Using Fulgent Genetics hype-based prediction, you can estimate the value of Fulgent Genetics from the perspective of Fulgent Genetics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Fulgent Genetics using Fulgent Genetics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Fulgent using crowd psychology based on the activity and movement of Fulgent Genetics' stock price.
Fulgent Genetics Implied Volatility | 1.1 |
Fulgent Genetics' implied volatility exposes the market's sentiment of Fulgent Genetics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Fulgent Genetics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Fulgent Genetics stock will not fluctuate a lot when Fulgent Genetics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Fulgent Genetics to buy its stock at a price that has no basis in reality. In that case, they are not buying Fulgent because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Fulgent Genetics after-hype prediction price | USD 16.81 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Fulgent contract
Based on the Rule 16, the options market is currently suggesting that Fulgent Genetics will have an average daily up or down price movement of about 0.0688% per day over the life of the 2025-04-17 option contract. With Fulgent Genetics trading at USD 16.87, that is roughly USD 0.0116 . If you think that the market is fully incorporating Fulgent Genetics' daily price movement you should consider acquiring Fulgent Genetics options at the current volatility level of 1.1%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Fulgent |
Fulgent Genetics After-Hype Price Prediction Density Analysis
As far as predicting the price of Fulgent Genetics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Fulgent Genetics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Fulgent Genetics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Fulgent Genetics Estimiated After-Hype Price Volatility
In the context of predicting Fulgent Genetics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Fulgent Genetics' historical news coverage. Fulgent Genetics' after-hype downside and upside margins for the prediction period are 14.11 and 19.51, respectively. We have considered Fulgent Genetics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Fulgent Genetics is not too volatile at this time. Analysis and calculation of next after-hype price of Fulgent Genetics is based on 3 months time horizon.
Fulgent Genetics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Fulgent Genetics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Fulgent Genetics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Fulgent Genetics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.11 | 2.71 | 0.06 | 0.16 | 8 Events / Month | 9 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
16.87 | 16.81 | 0.36 |
|
Fulgent Genetics Hype Timeline
Fulgent Genetics is currently traded for 16.87. The entity has historical hype elasticity of -0.06, and average elasticity to hype of competition of 0.16. Fulgent is forecasted to decline in value after the next headline, with the price expected to drop to 16.81. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.36%, whereas the daily expected return is currently at -0.11%. The volatility of related hype on Fulgent Genetics is about 192.09%, with the expected price after the next announcement by competition of 17.03. About 33.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.47. Some equities with similar Price to Book (P/B) outperform the market in the long run. Fulgent Genetics has Price/Earnings To Growth (PEG) ratio of 1.32. The entity recorded a loss per share of 1.41. The firm had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Fulgent Genetics Basic Forecasting Models to cross-verify your projections.Fulgent Genetics Related Hype Analysis
Having access to credible news sources related to Fulgent Genetics' direct competition is more important than ever and may enhance your ability to predict Fulgent Genetics' future price movements. Getting to know how Fulgent Genetics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Fulgent Genetics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ILMN | Illumina | (0.20) | 9 per month | 0.00 | (0.27) | 2.87 | (5.47) | 15.07 | |
| TTOO | T2 Biosystms | 0.00 | 0 per month | 0.00 | (0) | 17.14 | (17.78) | 130.00 | |
| A | Agilent Technologies | (1.94) | 10 per month | 0.00 | (0.07) | 2.92 | (2.59) | 9.03 | |
| MTD | Mettler Toledo International | 30.84 | 9 per month | 0.00 | 0.04 | 2.34 | (2.81) | 8.60 | |
| WAT | Waters | 0.74 | 9 per month | 0.00 | 0.04 | 2.95 | (2.93) | 10.90 | |
| DHR | Danaher | 0.44 | 8 per month | 0.00 | (0.02) | 2.19 | (2.24) | 12.14 | |
| TMO | Thermo Fisher Scientific | (10.97) | 9 per month | 0.00 | 0.04 | 2.40 | (2.39) | 10.04 | |
| CRL | Charles River Laboratories | (1.93) | 11 per month | 0.00 | (0.02) | 3.86 | (3.26) | 11.72 | |
| CDNA | Caredx Inc | 0.11 | 10 per month | 0.00 | (0.05) | 5.88 | (7.44) | 19.59 | |
| GH | Guardant Health | 1.63 | 10 per month | 3.49 | 0.10 | 6.28 | (5.93) | 32.66 | |
| EXAS | EXACT Sciences | (0.28) | 11 per month | 0.00 | (0.14) | 4.10 | (4.95) | 13.23 | |
| NTRA | Natera Inc | (0.87) | 9 per month | 0.00 | (0.02) | 4.36 | (5.71) | 13.77 | |
| TWST | Twist Bioscience Corp | 0.77 | 10 per month | 0.00 | (0.05) | 6.39 | (6.90) | 18.27 |
Fulgent Genetics Additional Predictive Modules
Most predictive techniques to examine Fulgent price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Fulgent using various technical indicators. When you analyze Fulgent charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Fulgent Genetics Predictive Indicators
The successful prediction of Fulgent Genetics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Fulgent Genetics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Fulgent Genetics based on analysis of Fulgent Genetics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Fulgent Genetics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Fulgent Genetics's related companies. | 2024 | 2025 (projected) | Dividend Yield | 0.0202 | 0.018 | Price To Sales Ratio | 1.97 | 1.87 |
Story Coverage note for Fulgent Genetics
The number of cover stories for Fulgent Genetics depends on current market conditions and Fulgent Genetics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Fulgent Genetics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Fulgent Genetics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Fulgent Genetics Short Properties
Fulgent Genetics' future price predictability will typically decrease when Fulgent Genetics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Fulgent Genetics often depends not only on the future outlook of the potential Fulgent Genetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Fulgent Genetics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 30.2 M | |
| Cash And Short Term Investments | 258.1 M |
Additional Tools for Fulgent Stock Analysis
When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.